Swiss National Bank Akouos, Inc. Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$7.65 - $11.38 $290,700 - $432,440	-38,000 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$9.93 - $13.59 $114,195 - $156,285	11,500 Added 43.4%	38,000 $441,000
Q2 2021 Aug 06, 2021	SELL	$11.87 - $15.96 $58,162 - $78,204	-4,900 Reduced 15.61%	26,500 $333,000
Q1 2021 May 07, 2021	BUY	$13.87 - $21.04 $166,440 - $252,480	12,000 Added 61.86%	31,400 $436,000
Q4 2020 Feb 05, 2021	BUY	$17.03 - $22.45 $330,382 - $435,530	19,400 New	19,400 $385,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.